Freenome | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for Freenome

Team Bitscale

12 Feb 2026 — 1 min read

Freenome

Overview

Freenome is an AI-driven biotechnology company based in South San Francisco, California, founded in 2014. The company focuses on developing blood-based early cancer detection tests using its proprietary multiomics platform, which integrates various biological data types to identify cancer at its earliest stages. Its mission is to make cancer screening accessible and effective, aiming to detect cancer when it is most treatable.

The primary product is its Early Cancer Detection Test, which currently targets colorectal cancer screening. The company is also working on detection solutions for other cancer types, including lung, prostate, breast, and pancreatic cancers. The technology has been clinically validated through studies and is preparing for FDA submission and commercialization. Freenome has raised $1.35 billion in funding and plans to go public through a merger in 2026, with future initiatives focused on expanding testing capabilities and improving data integration.

Basic Information

Industry	research
Founded	2014
Revenue	650M
Headquarters	3300 Marina Blvd, Brisbane, California 94005, United States
Languages	English
Alexa Ranking

Contact Details

Key Focus Areas & Initiatives

Molecular diagnostics
Multiomics research and platform development
Machine learning for healthcare applications
Blood-based cancer screening and early detection
AI-powered oncology solutions
Clinical trial enrollment and validation studies
Multi-cancer testing
Data-driven biomarker discovery and profiling
Biopharma partnerships and collaborations
Personalized and precision medicine
Non-invasive diagnostic technologies
Integration of genomics, proteomics, and epigenomics
Patient-centric care and health equity
Healthcare innovation and prevention strategies

Technologies Used

AI
ANGEL LMS
Act!
Amazon SES
Analyzer
Booz Allen Hamilton
Electron
Epic
Freshservice
Gmail
Google Apps
Google Kubernetes Engine (GKE)
IBM Storage Suite for IBM Cloud Paks
Jira
Kubernetes
Linkedin Marketing Solutions
Liquid
MailChimp SPF
Marketo
Medrio EDC
Micro
Microsoft Office 365
NetSuite
NovaSeq
OneTrust
Outlook
Pulumi
Python
Qubit Deliver
React
Remote
Salesforce
Salesforce CRM Analytics
Semrush
Slack
Tor
Veeva Vault
Veeva Vault eTMF

Affiliated Organizations & Regional Branches

Oncimmune - An Alden Scientific Company

Instantly AI Review 2026: Features, Pricing & Competitors

Outbound in 2026 doesn’t play by the old rules. Mailbox providers have tightened up, filters are sharper, and the old "spray and pray" routine that still worked a few years back will torch your domain reputation before lunch. If you’re an SDR, founder, agency operator, or

GTM Strategy: The Complete Guide (Framework, Examples & B2B Playbook)

Most things labeled a “GTM strategy” are really a channel checklist wearing a nice slide template. They are activity plans, not a coherent answer to how the business will create, capture, and deliver value for a specific buyer in a specific market. This is written for B2B founders, product marketers,

How Scrut.io Built a Compliance-Signal GTM Machine with Bitscale

Scrut Automation simplifies continuous compliance for cloud-native companies, helping them achieve ISO 27001, SOC 2, PCI DSS, and GDPR compliance 5x faster — with real-time risk monitoring and automated evidence collection.

Clay API Limits, Authentication & Rate Limits Explained

Your enrichment workflow ran perfectly on 50 test records. Then you pointed it at 10,000 contacts and everything collapsed: 429 errors, duplicate CRM writes, and a credit balance that evaporated overnight. The Clay API usually is not the root cause. The root cause is treating authentication, rate limits, and